2001
DOI: 10.1093/hmg/10.11.1191
|View full text |Cite
|
Sign up to set email alerts
|

A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse

Abstract: Sphingolipid activator proteins (saposins A, B, C and D) are small homologous glycoproteins derived from a common precursor protein (prosaposin) encoded by a single gene. They are required for in vivo degradation of sphingolipids with short carbohydrate chains. Six cysteines and one glycosylation site are strictly conserved in all four saposins. Total deficiency of all saposins and specific deficiency of saposin B or C are known among human patients. A mouse model of total saposin deficiency closely mimics the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

6
134
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 143 publications
(140 citation statements)
references
References 36 publications
6
134
0
Order By: Relevance
“…Saposin A is required for galactosylceramide degradation by galactosylceramide-␤-galactosidase. Mice lacking saposin A accumulate galactosylceramide and suffer from a form of Krabbe's disease (20). Saposin B facilitates the degradation of a variety of lipids, including sulfatide by arylsulfatase A and globotriaosylceramide and digalactosylceramide by ␣-galactosidase A.…”
mentioning
confidence: 99%
“…Saposin A is required for galactosylceramide degradation by galactosylceramide-␤-galactosidase. Mice lacking saposin A accumulate galactosylceramide and suffer from a form of Krabbe's disease (20). Saposin B facilitates the degradation of a variety of lipids, including sulfatide by arylsulfatase A and globotriaosylceramide and digalactosylceramide by ␣-galactosidase A.…”
mentioning
confidence: 99%
“…The saposin group of enzymes, which include saposin A, B, C and D derived from prosaposin by proteolytic cleavage, plays an indispensable role in activating the lysosomatic enzymes and preparing glycosphingolipidic substrates. [28][29][30] Two mechanisms of action appear to be involved in sphingolipid activator function. Some activators (e.g., saposin B) mobilize glycosphingolipids by loosening the sphingolipid's ceramide moiety within the membrane, thereby making the sphingolipid's glycosyl groups more accessible to sphingolipid hydrolases.…”
Section: Galc Gene Methylationmentioning
confidence: 99%
“…This finding has been used to establish a new mouse model in order to study CGD. 28 However, there is currently no data available regarding saposin gene transcription, translation or enzyme activity changes in cancer cells.…”
Section: Galc Gene Methylationmentioning
confidence: 99%
“…Examples of SAPLIP functions include roles in exohydrolase degradation of sphingolipids in the lysosome (saposins) (17), antimicrobial activity (granulysin and NK-lysin) (18), tumor lysis (NK-lysin) (19), pulmonary surfactant surface tension regulation (surfactant protein B) (20), and bacterial/eukaryotic cell lysis (amoebapores) (21).…”
mentioning
confidence: 99%